“I consider myself an environmentalist and a public health advocate” said Rasoulpour, who leads a team developing new tools for farmers while also ensuring that “the human health and environmental safety profile for the new products is always more favorable than the products they are replacing.”
Nagy leads the medical team at one of the nation’s top health care systems. “Education, research and clinical medicine—most hospitals do that to some degree,” Nagy said. “We do it to the max on all fronts.”
A rising-star diabetes researcher, Teresa Mastracci was recruited as the Indiana Biosciences Research Institute’s first independent investigator.
Jill Margetts joined Centerfield in 2007—which has invested in more than 40 companies—near the end of its first fund and during the launch of its second. It’s now on its fourth, “and with each new fund, the firm’s size and investor base has grown,” she said.
Tiffany Kyser works with scholars, researchers and educators in 13 states to ensure that schools and state departments of education abide by civil rights laws. In her downtime, she’s helping to change the face of the east side.
After working his way up through the Pacers organization, Peter Dinwiddie knows the game inside and out.
One of only a few African-American women in biomedical science, Baindu Lucy Bayon is earning recognition for her own research and for her steadfast outreach to help open doors for others in STEM fields.
Dow Chemical Co. and DuPont Co. say they're willing to make more business divestments as a way to nudge European regulators who remain wary of their proposed merger.
The open-wheel racing series will spend up to half of its marketing budget this year on digital and social media, up from about 20 percent last season.
The use of funds generated through privatization of public resources seems like a quick fix to a short-term budget gap.
Jim McClelland will focus on reducing the number of deaths from overdoses, expanding access to evidence-based treatment for those who are addicted, and reducing exposure of Hoosiers to opioids.
A new archives building has been on the public radar since a moment 20 years ago when water leaks at the Indiana State Library threatened to destroy some of our most important and irreplaceable history.
I have found through researching the famous walls of history that they all have one thing in common: Their intended purpose and usefulness are uniformly temporary.
Right now, Indiana is not ready to provide universal, statewide pre-K.
At a time when everything indicates more should be done to spread state-funded pre-K statewide, the tendency of many legislative leaders is to dawdle
The Indianapolis-based drugmaker has offered many of its research and development employees a compensation package if they leave the company.
The station continues to revamp its morning newscasts, which have struggled in the ratings. Three of its morning personalities have been replaced in the last three months.
How do we make Mexico pay for the wall? “Mexico” is a nation-state abstraction. Economists insist all costs are borne by people, not legal entities called countries or corporations.
In his first week in the White House, Donald Trump exceeded my expectations—and not in a good way.
For drugmakers, including Indianapolis-based Eli Lilly and Co., a meeting Tuesday with President Donald Trump was a dose of happy pills.
